I Service de Nephrologie, Hopital Saint-Charles, Montpel/ier, France; 2 Department of Medicine, University of Sydney, Sydney; 3Department of Medicine, St. Vincent's Hospital, Melbourne; 4Centrefor Biomedical Engineering, University of New South Wales, Kensington, New South Wales 2033, Australia. Summary A technique allowing short-term blood access for extracorporeal therapy in rabbits is described. The technique utilizes silicone rubber cannulae and teflon vessel tips to construct an externalized carotidjugular arteriovenous shunt. The insertion procedure takes 1 hand extracorporeal blood flows in excess of 10 ml/min are obtainable for up to 7 days. Blood flow may still be obtained following shunt clotting by insertion of smaller diameter catheters through the arterial cannula. This technique has been successfully used for extracorporeal therapy in rabbit disease models.
Previous workers attempting extracorporeal therapy
with the rabbit have achieved vascular access via ear veins or arteries which often only allowed access twice or 3 times before vessels thrombosed (Antony, Pollard & McLeod, 1981) , and only allowed blood flow rates of up to 6 ml/min.' Such methods do not allow an accurate assessment of extracorporeal treatment techniques which require intensive early treatment application to affect the course of the disease. Long-term vascular access which does not interfere with the animal's normal activity has been achieved in larger animals such as dogs and sheep. The techniques which have been described include arteriovenous (A V) shunts, A V fistulae and atrial catheterization (Dennis, Cole & Scribner, 1974) . Only one similar procedure has been reported in rabbits (Mashiah, Marcus, Savin & Margel, 1984) .
This paper describes a procedure initially developed to gain vascular access in rabbits and meeting the following criteria:
(i) ease of access insertion; (ii) blood flow rates of to ml/min;
(iii) maintenance of flow rates for 5-8 days;
(iv) access to be tolerated by the animal. To meet the requirements, an A V shunt between the carotid artery and the jugular vein was developed in the experimental animals.
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Materials and methods
Shunt tubing consisted of 2 81m ID, 4 mOl OD silicone rubber (A.A. Rubber Co., Sydney, Australia) of 9 em lengths. Before use, the silicone tubing was soaked overnight in 35% 1-1202 then boiled in distilled water for 4 h to remove residual H 2 0 2 . This process removes surface contaminants and inactivates non polymerized sites in the rubber. Teflon tubing, 1· 7 81m ID, 2· 3 mOl OD and typically 25 mOl long (UNASCO, Sydney, Australia) was used to connect shunt tubing to vessels. All materials were autoclaved before use. Shunt insertions were performed in rabbits (NZ white) weighing 2-4 kg.
Anaesthesia
was induced by i.v. propanidid and maintained with a halothane/02 mixture via a mask; a skin incision was made following the anterior border of the sternomastoid from the angle of the jaw to the mid-clavicle.
The surgery was then performed in 3 stages.
Dissection and vessel isolation
The external jugular vein was located by blunt dissection through the connective tissue and fat anterior to the sternomastoid and isolated on 2 long (00) silk sutures which were left untied. The carotid artery was then approached by dividing the sternomastoid medial to the vein and 1 em of the vessel was isolated with (00) silk sutures, again left untied.
Insertion of cannulae and tips
Teflon tips were inserted into arterial and venous sections of silicone tubing which were then filled with heparinized saline (200 lU/ml) and clamped distally. Fig. 1 shows a schematic of shunt insertion into vessels. The insertion technique was the same for both vessels with carotid cannulation preceding venous cannulation.
The proximal end of the vessel was clamped using a soft vascular clamp (modified hair clip) and the distal end tied off, leaving the ties long. A 1mm incision was then made perpendicularly through the vessel wall and the teflon tip was inserted 5 mm into the vessel and the proximal suture tied firmly around it as close to the cannula as possible. Vessel and cannula were anchored together with the distal suture and then proximal and distal sutures were tied firmly together preventing the tip from slipping out of the vessel. Following a check of blood flow, the cannula was flushed with 3 ml of heparinized saline (200 IU/ml) and clamped distally.
The IlUlscle was then closely sutured over the arterial cannula aligning the vessel and cannula to minimize possible kinking. The venous cannula was sutured to muscle.
Subcutaneous tunnelling
The exit sites of the cannulae from the skin must be positioned such that the animal cannot damage or uncouple the shunt and subcutaneous alignment must preclude any likelihood of kinking or occlusion. Fig. 2 schematically outlines subcutaneous tunnels and shunt exit positions.
For the arterial cannula, a tunnel was made around the front of the ear with the exit behind the ear. This was done in 2 stages; the first tunnel following the line of the vessel and the second taking the cannula behind the ear. The venous cannula tunnel was made similarly with an exit behind and below the ear. External connection of the cannula was made behind the ear with a teflon connector approximately 15 mm in length. The A V connection was taped to prevent accidental disconnection.
Results and discussion
Shunt insertion time was approximately 60 min and rabbits were active within 1 h of cessation of anaesthesia. Blood flow rates of 10 ml/min could be obtained from shunts while they remained patent. The mean period of shunt patency without the need for declotting was 5·8 ± 1·7 days. Declotting often prolonged the period of viable access, the mean period of available access increasing to 6·7 ± 1·5 days. The externalized shunt was generally not damaged by the rabbit because of the inaccessibility of the shunt behind the ear.
The technique described is well suited to pro-tocols requiring frequent vascular access with high blood flow rates in rabbits. Once the shunt is in place blood access can be obtained within minutes even when declotting is required to achieve the necessary blood flow. In our hands, the technique is being used to assess the efficacy of plasma exchange in the treatment of autoimmune disease. In this study, no continuous anticoagulation was used because of possible interference with the disease models being investigated. However, the use of anticoagulants such as oral warfarin or infused heparin would be expected to extend the period of clot-free shunt function (Dennis, Cole & Scribner, 1974) .
animal physically damaged the shunt. However, it was necessary to maintain the rabbits in inctivictual cages to prevent other rabbits from chewing through the shunts.
When shunts clotted, the obstruction generally occurred at the arterial vessel tip. The obstruction could usually be cleared by simply drawing out the clot via catheter and syringe with subsequent flushing. If clotting was more severe a 19 g catheter (Intracath, Deseret Co., Sandy, Utah, USA) was fitted so that it reached the vessel tip when the outside of the luer fitting was sealed against the silicone tubing, then a 21 g catheter was passed through the 19 g catheter and vessel tip and beyond the thrombus. 
